Association between serum leptin concentrations and bone mineral density, and biochemical markers of bone turnover in adult men

Sato, M.; Takeda, N.; Sarui, H.; Takami, R.; Takami, K.; Hayashi, M.; Sasaki, A.; Kawachi, S.; Yoshino, K.; Yasuda, K.

Journal of Clinical Endocrinology and Metabolism 86(11): 5273-5276

2001


ISSN/ISBN: 0021-972X
PMID: 11701691
DOI: 10.1210/jcem.86.11.8020
Accession: 003654344

Download citation:  
Text
  |  
BibTeX
  |  
RIS

Article/Abstract emailed within 0-6 h
Payments are secure & encrypted
Powered by Stripe
Powered by PayPal

Abstract
Leptin, the product of the ob gene, has been shown to inhibit bone formation in mice. We addressed whether leptin has any role in the regulation of bone mineral density (BMD) in humans. Subjects were 221 adult men with a mean (+/-SD) age and body mass index of 52.1 +/- 8.7 yr and 23.6 +/- 2.8 kg/m2. Serum leptin, carboxyterminal propeptide of type 1 procollagen (PICP; a marker of bone formation), and cross-linked carboxyterminal teleopeptide of type 1 collagen (a marker of bone resorption) were measured by RIA. BMD was assessed by single photon absorptiometry, and total fat mass was determined by bioimpedance analysis. BMD was inversely associated with serum leptin concentrations and total fat mass after adjustment for body weight. PICP, but not cross-linked carboxyterminal teleopeptide of type 1 collagen, was inversely correlated with serum leptin. These results may suggest that an increase in serum leptin reduces bone formation and decreases BMD in adult men. Leptin may be a regulator of BMD in humans.